When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.
Be alerted of any news about your stocks and see what other stocks are trending.
CPRX - Catalyst Pharmaceuticals: A Potential Double In 2020
Catalyst Pharmaceuticals Inc.
General Background
Founded in 2002, Catalyst Pharmaceuticals (CPRX) specializes in obtaining treatments for rare diseases, many of which have no FDA-approved treatment options. Much of this article focuses on the current status of the company, with particular emphasis on the many catalysts for this upcoming year. There are also many references to important statements made by management during the November, 13, 2019 conference call. Overall, with the stock trading at $4.50-4.75 and with the company projected to become profitable this year, Catalyst is likely a great value play. Cantor Fitzgerald has a price